Product
Allogenic placenta derived mesenchymal stem cells
1 clinical trial
3 indications
Indication
Multiple SclerosisIndication
Secondary Progressive Multiple SclerosisIndication
mesenchymal stem cellsClinical trial
An Open-label, Non-randomized, Phase I Study of Allogeneic Placenta Derived Mesenchymal Stem Cells in Patients With Secondary-Progressive Multiple Sclerosis (SPMS),Status: Completed, Estimated PCD: 2024-03-04